Final answer:
In a child with cerebral palsy, medications such as baclofen, diazepam, and botulinum toxin must be monitored closely for alterations in therapeutic level to maintain efficacy and minimize side effects.
Step-by-step explanation:
When caring for a child with cerebral palsy, it is crucial to monitor medications closely due to potential changes in therapeutic levels. Medications that are commonly used to manage spasticity and muscle tone in children with cerebral palsy include baclofen, diazepam, and botulinum toxin. These drugs must be managed carefully to avoid adverse effects and to ensure they remain effective. For instance, baclofen can cause side effects such as drowsiness or weakness, and requiring dose adjustments based on the individual response of the child. Regular blood tests and clinical evaluations are essential to ensure the medication is at a therapeutic level that provides benefit without causing harm.
Specifically, when a child with cerebral palsy is prescribed a medication like intrathecal baclofen, which is delivered directly to the spinal fluid, serum levels are not as helpful, but the pump function and symptom control need close assessment to ensure proper dosage and efficacy. Benzodiazepines like diazepam are known for their potential interaction with other medications, and their effects can be potentiated, thus necessitating regular monitoring of their therapeutic levels and patient response.